Skip to content

Pilot Study for a Machine Learning Test for Migraine

Pilot Study for Machine Learning as Applied to EEG as an Aid to the Diagnosis of Adult Migraineurs Without Aura, or Migraineurs With Aura on Interictal (Non-pain) Days

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05517200
Acronym
MLTM
Enrollment
20
Registered
2022-08-26
Start date
2022-09-03
Completion date
2025-06-30
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Migraine, Migraine, Tension-Type Headache

Keywords

EEG, Machine Learning, Migraine, Headache, Diagnosis, Artificial Intelligence

Brief summary

This study is a single center, random participant selection, data analyst is blinded to patient identifiers, controlled clinical trial. The proposed study is intended to establish safety and efficacy of quantifiable electrical biomarkers for migraine that can be used to confirm a diagnosis in people that have already been screened as positive for migraine using the gold standard participative criteria set out in the International Classification of Headache disorders-3 (ICHD-3) criteria. It is hypothesized that specific brain signals can be used to distinguish between migraine patients with and without aura from normal control and tension- type headache control participants by EEG enhanced with machine learning software.

Interventions

DIAGNOSTIC_TESTMachine Learning Test for Migraine

Resting EEG, and Visual and Auditory Stimulation

Sponsors

Headache Sciences Incorporated
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* ● Age range: All participants and controls will be adults over 18, and no greater than 70 * Sex: Migraine patients and controls to reflect the demographics of the disease such that there is a balanced mix of males to females that reflects known female to male ratio for migraine is 3 to 1. * Capable of giving clear and reliable answers on the questionnaires * All potential participants should be able to read, write and speak in English: unless they can bring a translator. * All mentally competent: to give accurate answers on questionnaires, to decide for themselves and sign the informed consent form. * All medically stable patients. * Capable of safely using a staircase to our downstairs lab * OHIP must be up-to-date and participants must show a valid OHIP number * Able and willing to comply with all study requirements * Normal controls must be very healthy.

Exclusion criteria

* ● Under 18 years old * Over 70 years old (71 and above) * Incompetent in english language and no translator (This applies to reading, writing and speaking.) * Current moderate or serious mental illness (including depression, anxiety disorder, psychosis) * Mentally disabled/ Mentally incompetentHistory of photo-epilepsy or history of seizure following shortly after visual stimulus such as bright or repetitive flashes of light, repetitive flashes of light (such as at a disco, or looking at an overhead fan), or after looking at repetitive visual patterns lines such as looking at multiple stripes or squares, or from seeing movement such as when watching an action movie. * Medically unstable * Prisoner * Unable to go down the stairs (if recording is downstairs) * Pacemaker * Defibrillator * Cochlear implants * Significant skull deformity (e.g. a depression of greater than half an inch * Head injury with consciousness loss in the last year, even with apparent full recovery. * Severe facial trauma within the last three months, or longer if unrecovered. * Unnatural material inside the head or mouth based on history (including clips from surgery, shrapnel, bullet, medical pump, wires, medical device, metal dental implants) * Chronic communicable diseases carried (including Hepatitis B, Hepatitis C, HIV, Creutzfeldt-Jakob Disease) Note: Vagal stimulator and insulin pump are not an

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of machine learning as applied to EEG to diagnose migraine.2 yearsThe primary endpoint is a sensitivity of 79% and a specificity of 72% in distinguishing migraine with and without aura screened using the ICHD-3 benchmark criteria as compared to normal controls.

Countries

Canada

Contacts

Primary ContactMark S. Doidge, MD, BA
headachesciences@gmail.com6472072504
Backup ContactGaurav Anand, MD, BSc
13gaurav.anand13@gmail.com6479953374

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026